Mannkind (MNKD) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.44% |
| Dec 31, 2025 | 48.80% |
| Sep 30, 2025 | 38.90% |
| Jun 30, 2025 | 31.99% |
| Mar 31, 2025 | 38.59% |
| Dec 31, 2024 | 33.26% |
| Sep 30, 2024 | 37.30% |
| Jun 30, 2024 | 40.25% |
| Mar 31, 2024 | 36.64% |
| Dec 31, 2023 | 34.56% |
| Sep 30, 2023 | 47.84% |
| Jun 30, 2023 | 38.21% |
| Mar 31, 2023 | 36.95% |
| Dec 31, 2022 | 28.41% |
| Sep 30, 2022 | 39.07% |
| Jun 30, 2022 | 29.20% |
| Mar 31, 2022 | 29.34% |
| Dec 31, 2021 | 24.57% |
| Sep 30, 2021 | 19.90% |
| Jun 30, 2021 | 12.64% |
| Mar 31, 2021 | 27.91% |
| Dec 31, 2020 | -2.99% |
| Sep 30, 2020 | -19.21% |
| Jun 30, 2020 | -21.85% |
| Mar 31, 2020 | -25.94% |
| Dec 31, 2019 | -24.98% |
| Sep 30, 2019 | -24.46% |
| Jun 30, 2019 | -19.12% |
| Mar 31, 2019 | -14.78% |
| Dec 31, 2018 | -16.07% |
| Sep 30, 2018 | -30.89% |
| Jun 30, 2018 | -21.79% |
| Mar 31, 2018 | -22.06% |
| Dec 31, 2017 | -19.57% |
| Sep 30, 2017 | -23.12% |
| Jun 30, 2017 | -19.88% |
| Mar 31, 2017 | -19.46% |
| Dec 31, 2016 | -11.71% |
| Sep 30, 2016 | -15.57% |
| Jun 30, 2016 | -9.40% |
| Dec 31, 2015 | -14.54% |